Searle - PDFSEARCH.IO - Document Search Engine

Searle
Results: 315

#	Item
191	NDA[removed]S-005 Page 3 COVERA-HS - verapamil hydrochloride tablet, extended release G.D. Searle LLC[removed]COVERA-HS® (verapamil hydrochloride) Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-06-30 11:59:05 Nitriles Calcium channel blockers Cardiac dysrhythmia Antiarrhythmic agents Verapamil Amides Digoxin Cardioversion Atrial fibrillation Medicine Chemistry Cardiology
192	CANTERBURY HIGH SCHOOL Ottawa District School Board Health and Physical Education Department Semester II – [removed] –Course Outline Course Instructor: Kelly Searle _____________________________________________________ Add to Reading List Source URL: canterburyhs.ocdsb.ca Language: English - Date: 2011-03-11 09:16:24 Evaluation Standards-based education Educational assessment Thought Summative assessment Rubric E-learning Cooperative learning Course evaluation Education Evaluation methods Educational psychology
193	Disclosure Document for an 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:16 Arthritis Connective tissue diseases COX-2 inhibitors Sulfonamides Celecoxib G. D. Searle & Company Rheumatoid arthritis Juvenile idiopathic arthritis Non-steroidal anti-inflammatory drug Health Medicine Pfizer
194	Disclosure Document for an 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:20 Arthritis Connective tissue diseases COX-2 inhibitors Dow Jones Industrial Average Celecoxib G. D. Searle & Company Rheumatoid arthritis Juvenile idiopathic arthritis Non-steroidal anti-inflammatory drug Health Medicine Pfizer
195	Disclosure Document for an 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:20 Arthritis Connective tissue diseases COX-2 inhibitors Non-steroidal anti-inflammatory drugs Celecoxib G. D. Searle & Company Juvenile idiopathic arthritis Rheumatoid arthritis Health Medicine Pfizer
196	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:21 Arthritis Connective tissue diseases Rheumatology COX-2 inhibitors Celecoxib G. D. Searle & Company Rheumatoid arthritis Juvenile idiopathic arthritis Food and Drug Administration Health Medicine Pfizer
197	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Language: English Pfizer Anatomy Arthritis Connective tissue diseases COX-2 inhibitors Celecoxib Juvenile idiopathic arthritis Rheumatoid arthritis G. D. Searle & Company Medicine Health Rheumatology
198	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-14 08:23:24 Arthritis Connective tissue diseases Rheumatology Anatomy COX-2 inhibitors Celecoxib Juvenile idiopathic arthritis G. D. Searle & Company Rheumatoid arthritis Medicine Health Pfizer
199	This project was made possible by The Searle Family Fund At The Chicago Community Trust We also thank: Add to Reading List Source URL: www.marigallagher.com - Date: 2010-08-11 00:43:06
200	This project was made possible by The Searle Family Fund At The Chicago Community Trust We also thank: Add to Reading List Source URL: www.marigallagher.com - Date: 2010-08-11 00:43:06

UPDATE